Controlled substances have historically been problematic for governments concerned with policing usage. The primary targets have traditionally been the most well-liked sub culture drugs such as marijuana. In the last couple of years they’ve been imitated and manufactured as synthetic drugs. These synthetic drugs were being sold as Legal High Products.
The new Manmade Drug Control Act is intended to limit the distribution and usage of man-made drugs. It received approval by House legislators in December 2011, and would momentarily classify these substances as Schedule I drugs. Schedule I Controlled Substances – Substances in this schedule have a high potential for abuse, have no accepted medical use in treatment in the U. S. , and there is a shortage of accepted safety for use of the drug or other substance under clinical supervision. Some examples of substances listed in schedule I are as follow: heroin, lysergic acid diethylamide (LSD), weed (marijuana), peyote, methaqualone, and 3, 4-methylenedioxymethamphetamine (“ecstasy”).
Advances in technology have developed the power to test any potential drug user, particularly in terms of maintaining employment. Many previous users of detectable drugs have changed to the testing process by changing to designer drugs made of different chemicals that produce similar effects to other commoner substances; this is undeniably true of pot.
Substitute forms of substances, essentially ketamine-based products called “K-2” or “Spice,” are now simple to order online and the important ingredients are not traceable with any urinalysis as the chemical makeups are different. The ketamine physical effect is analogous to pot. In actual fact the designer drugs are often more potent, more uniform, and cheaper. These sorts of products are also ingested by smoking, just like cannabis. These knock-offs are frequently referred to as “legal highs.”
States are having a tricky time addressing this designer drug quandary as the laws against the standard drugs are based on the active ingredient. Delta-9-tetrahydrocannebanol, or THC, is the active agent in cannabis and must be present for any court conviction. Designer drugs have mimic chemicals at the core of the compound and those chemicals must be pinpointed and included in legislation and the developers frequently use chemical combinations.
Additionally, while the states are busy trying to combat the issue with new laws, the designer drug developers are busy staying one jump ahead by identifying a new blend of chemicals which will provide for a new product, often putting legislators back at square one.